Hydrochlorothiazide
Drug · tier A · 8 trials (1 recruiting) · 11 publications · score 79.0
Rimonabant
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 79.0
Topiramate
Drug · tier A · 8 trials (0 recruiting) · 15 publications · score 77.0
Liraglutide
Drug · tier A · 8 trials (0 recruiting) · 19 publications · score 76.5
Orlistat
Drug · tier A · 8 trials (0 recruiting) · 12 publications · score 74.0
Metoprolol
Drug · tier A · 7 trials (1 recruiting) · 10 publications · score 68.5
Nicotine
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 68.5
Acetazolamide
Drug · tier A · 4 trials (0 recruiting) · 13 publications · score 61.0
Metformin Hydrochloride
Drug · tier A · 8 trials (1 recruiting) · 5 publications · score 54.5
Chlorothiazide
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 49.0
Atenolol
Drug · tier A · 2 trials (0 recruiting) · 7 publications · score 44.0
Chlorthalidone
Drug · tier A · 2 trials (0 recruiting) · 5 publications · score 37.0
Cannabidiol
Drug · tier A · 6 trials (0 recruiting) · 2 publications · score 36.0
Azathioprine
Drug · tier A · 0 trials (0 recruiting) · 5 publications · score 30.0
Dronabinol
Drug · tier A · 2 trials (0 recruiting) · 2 publications · score 29.0
Ribavirin
Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 26.0
Nabilone
Drug · tier A · 1 trials (0 recruiting) · 1 publications · score 23.5
Acetazolamide Sodium
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 22.5
Research map, not treatment advice. Built 2026-10-07.